OPKO Health says $121 million convertible notes become convertible, will settle in stock
OPKO Health determined on October 1, 2026 that its 3.75% Convertible Senior Notes due 2029, with about $121 million outstanding, are convertible by holders through December 31, 2026, because the stock traded above the trigger price for enough days in the quarter ended September 30, 2026. The company has elected to settle conversions in common stock, which could add shares for existing holders.
Key points
- Notes outstanding: about $121 million; conversion right triggered by closing price above $1.495, or 130% of the $1.15 conversion price, for at least 20 of 30 consecutive trading days
- Notes convertible through December 31, 2026, and may be convertible after that if Indenture conditions are met in future measurement periods
- Holders converting receive 869.5652 common shares per $1,000 principal, plus any additional shares under the Indenture's early conversion provisions
- U.S. Bank Trust Company, National Association is trustee and conversion agent
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 02, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.